Non-antibiotic Management in Acute Uncomplicated Diverticulitis
NCT07625267 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL
Last updated 2026-08-31
Summary
Diverticulitis is a common condition that causes swelling and pain in part of the colon (the large intestine). Doctors classify it as "mild" when there are no serious complications.
For many years, doctors in the United States have treated mild diverticulitis with antibiotics. New studies from Europe suggest that many people with mild diverticulitis may not need antibiotics and can get better with just pain medicines. But this approach has not been tested in the United States, where antibiotics are still the standard treatment.
The goal of this clinical trial is to find out if people with mild diverticulitis can be safely treated at home without antibiotics. The main questions it aims to answer are:
* Are people treated without antibiotics admitted to the hospital more often than people treated with antibiotics?
* Do people treated without antibiotics have more emergency room visits, worsening of their disease, or need for surgery?
Researchers will compare two groups of people who come to the emergency department with mild diverticulitis to see if treatment without antibiotics is as safe as treatment with antibiotics.
Participants will:
* Be sent home with pain medicines (ibuprofen and acetaminophen) only, or with pain medicines plus an antibiotic taken by mouth for 7 days
* Follow a liquid diet and slowly return to normal food as they feel better
* Come back to clinic for a check-up at 1 to 2 weeks
* Answer phone calls about their health at 4 weeks, 3 months, and 6 months
Conditions
- Acute Uncomplicated Diverticulitis
Interventions
- DRUG
-
Symptomatic treatment (ibuprofen and acetaminophen)
Oral ibuprofen 400 mg every 8 hours and/or oral acetaminophen 1 g every 8 hours, taken as needed for pain control for up to 7 days, combined with a liquid diet advancing as tolerated and standardized return precautions. This symptomatic regimen is administered to participants in both study arms.
- DRUG
-
Amoxicillin-clavulanate
Oral amoxicillin/clavulanate 875/125 mg every 12 hours for 7 days, administered to participants in the antibiotic arm who do not have a documented or self-reported penicillin or beta-lactam allergy. Administered in addition to the symptomatic treatment regimen.
- DRUG
-
Ciprofloxacin plus metronidazole
Oral ciprofloxacin 500 mg every 12 hours plus oral metronidazole 500 mg every 8 hours for 7 days, administered to participants in the antibiotic arm who have a documented or self-reported penicillin or beta-lactam allergy. Administered in addition to the symptomatic treatment regimen as an alternative to amoxicillin/clavulanate.
Sponsors & Collaborators
-
Montefiore Medical Center
lead OTHER
Principal Investigators
-
James Taylor, MD · Montefiore Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-07-01
- Primary Completion
- 2028-06-30
- Completion
- 2028-06-30
- FDA Drug
- Yes
More Related Trials
-
Prospective Study of Clostridium Difficile in Children Undergoing Colonoscopy
NCT01472978 ·Status: WITHDRAWN ·Phase: NA
-
Characterization of Pain Processing Mechanisms in Irritable Bowel Syndrome
NCT00108446 ·Status: COMPLETED ·Phase: PHASE2
-
Symptomatic Treatment of Acute Uncomplicated Diverticulitis
NCT02219698 ·Status: COMPLETED ·Phase: NA
-
The Effect of Prebiotics on the Microbiome in Irritable Bowel Syndrome Patients: The Diet and Microbiome Study
NCT01829932 ·Status: COMPLETED ·Phase: NA
-
Colon Capsule Endoscopy in Patients With Colonic Diverticulitis
NCT05700981 ·Status: UNKNOWN ·Phase: NA
-
Randomized Multicentric Trial to Evaluate a Free Diet With a Progressive Diet in the Treatment of Acute Diverticulitis (DIVERDIET)
NCT03496090 ·Status: COMPLETED ·Phase: NA
-
Analysis of the Role of the Microbiota in Diverticular Disease
NCT07681505 ·Status: NOT_YET_RECRUITING
-
Pathophysiological Effects of Persistently Colonized Microbiome on Irritable Bowel Syndrome
NCT06013410 ·Status: RECRUITING ·Phase: NA
-
PCT REveals Good Recovery After Acute Diverticulitis: the PREGRAD Study
NCT02817854 ·Status: UNKNOWN
-
DEBUT: Diverticulitis Evaluation of Patient Burden, Utilization, and Trajectory
NCT02776787 ·Status: COMPLETED
-
Improving Medication Adherence in Pediatric Inflammatory Bowel Disease
NCT01536509 ·Status: COMPLETED ·Phase: NA
-
Diet Intervention Treatment for Active Ulcerative Colitis
NCT04121806 ·Status: RECRUITING ·Phase: NA
-
A Pilot Study of Cognitive-Behaviour Therapy for Irritable Bowel Syndrome and the Gut Microbiome
NCT02313246 ·Status: TERMINATED ·Phase: NA
-
Response of Clostridium Difficile Infection to Metronidazole Therapy
NCT00304369 ·Status: COMPLETED
-
Antibiotics as an Adjuvant in Patients With Acute Severe Ulcerative Colitis
NCT03794765 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy of Hyperbaric Oxygen-assisted Treatment for ASUC and Refractory IBD
NCT07257588 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Harnessing the Healthy Gut Microbiota to Cure Patients With Recurrent C. Difficile Infection
NCT01372943 ·Status: TERMINATED ·Phase: NA
-
The Effects of Bifidobacterium Breve Bif195 for Diarrhea-predominant Irritable Bowel Syndrome
NCT04808271 ·Status: COMPLETED ·Phase: NA
-
Lactoferrin for the Treatment of Symptomatic Uncomplicated Diverticular Disease
NCT03490279 ·Status: UNKNOWN ·Phase: NA
-
Small Bowel Transit Time in Clostridium Difficile Colitis
NCT01309750 ·Status: TERMINATED
-
The Role of Mucosal Microbiome in Recurrence of Clostridioides Difficile Infection
NCT04675723 ·Status: COMPLETED
-
Mindfulness-Based Eating in Patients With Irritable Bowel Syndrome
NCT02681666 ·Status: COMPLETED ·Phase: NA
-
Epidemiology and Pathophysiology of Post-Infectious Functional GI Disorders
NCT03266068 ·Status: COMPLETED
-
The Role of Mucosal Microbiome in the Development, Clearance and Recurrence of Clostridioides Difficile Infection
NCT04679324 ·Status: WITHDRAWN
-
Single-center Exploratory Study of the Intestinal Microbiota in Patients Treated for Irritable Bowel Syndrome With Predominant Constipation and Methane Production
NCT06801184 ·Status: RECRUITING